Related references
Note: Only part of the references are listed.Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Miwako Kobayashi et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018
Antoni Torres et al.
CLINICAL INFECTIOUS DISEASES (2021)
Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18
Harry Pick et al.
THORAX (2020)
Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: Emergence of drug-resistant non-vaccine serotypes
So Hyun Kim et al.
VACCINE (2020)
Burden of Community-Acquired Pneumonia and Unmet Clinical Needs
Joao Ferreira-Coimbra et al.
ADVANCES IN THERAPY (2020)
Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014-2018
Zahin Amin-Chowdhury et al.
CLINICAL INFECTIOUS DISEASES (2020)
Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009-2017
Jose A. Suaya et al.
JOURNAL OF INFECTION (2020)
Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013-2017
Reiko Shimbashi et al.
EMERGING INFECTIOUS DISEASES (2020)
Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia
Raul E. Isturiz et al.
VACCINE (2019)
Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)
Eiichiro Sando et al.
VACCINE (2019)
Distribution and annual changes in the proportion of Streptococcus pneumoniae serotypes in Japanese adults with pneumococcal pneumonia from 2011 to 2017
Shingo Noguchi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2019)
Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)
Jason J. LeBlanc et al.
VACCINE (2019)
Decreasing case fatality rate following invasive pneumococcal disease, North East England, 2006-2016
C. Houseman et al.
EPIDEMIOLOGY AND INFECTION (2019)
Accuracy of High-Throughput Nanofluidic PCR-Based Pneumococcal Serotyping and Quantification Assays Using Sputum Samples for Diagnosing Vaccine Serotype Pneumococcal Pneumonia: Analyses by Composite Diagnostic Standards and Bayesian Latent Class Models
Satoshi Kakiuchi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016
Walter H. B. Demczuk et al.
VACCINE (2018)
Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010-2017
Kimiko Ubukata et al.
EMERGING INFECTIOUS DISEASES (2018)
Demonstration of the herd effect in adults after the implementation of pneumococcal vaccination with PCV13 in children
C. Hays et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
The distribution and annual changes in the Streptococcus pneumoniae serotypes in adult Japanese patients with pneumococcal pneumonia from 2011 to 2015
Kentaro Akata et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2017)
Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study
Motoi Suzuki et al.
LANCET INFECTIOUS DISEASES (2017)
Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature
Gal Tsaban et al.
VACCINE (2017)
Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis
Tinevimbo Shiri et al.
LANCET GLOBAL HEALTH (2017)
Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia
Chamira Rodrigo et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
Pauline A. Waight et al.
LANCET INFECTIOUS DISEASES (2015)
Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine
Shigeru Suga et al.
VACCINE (2015)
The Burden and Etiology of Community-Onset Pneumonia in the Aging Japanese Population: A Multicenter Prospective Study
Konosuke Morimoto et al.
PLOS ONE (2015)
Changes in Pneumococcal Serotypes and Antimicrobial Resistance after Introduction of the 13-Valent Conjugate Vaccine in the United States
Sandra S. Richter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study
Hajime Fukuyama et al.
BMC INFECTIOUS DISEASES (2014)
Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia
Yuichiro Shindo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes
C. Garcia-Vidal et al.
THORAX (2010)
Holiday Spikes in Pneumococcal Disease among Older Adults
Nicholas D. Walter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia
Gavin Barlow et al.
THORAX (2007)
Share Paper
